Retrospective, Multicentre Matched Cohort Study Comparing Safety and Efficacy Outcomes of Intermittent Infusion and Continuous Infusion Vancomycin

被引：0
|
作者：
Ma, N. [1 ,2 ]
Walker, S. A. N. [1 ,2 ,3 ,4 ]
Elligsen, M. [1 ]
Palmay, L. [1 ]
Ho, G. [5 ]
Leis, J. A. [3 ,4 ,6 ]
Bansal, V [7 ]
Powis, J. [5 ,6 ]
机构：
[1] Sunnybrook Hlth Sci Ctr, Dept Pharm, Bayview Campus, Toronto, ON, Canada
[2] Univ Toronto, Leslie L Dan Fac Pharm, Toronto, ON, Canada
[3] Sunnybrook Hlth Sci Ctr, Div Infect Dis, Toronto, ON, Canada
[4] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON, Canada
[5] Michael Garron Hosp, Toronto, ON, Canada
[6] Univ Toronto, Fac Med, Toronto, ON, Canada
[7] Sunnybrook Hlth Sci Ctr, Holland Orthoped & Arthrit Campus, Toronto, ON, Canada
来源：
CANADIAN JOURNAL OF HOSPITAL PHARMACY | 2019年 / 72卷 / 01期
关键词：
vancomycin; intermittent infusion; continuous infusion; safety; efficacy;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：62 / 62
页数：1
相关论文
共 50 条
  • [31] CONTINUOUS VERSUS INTERMITTENT VANCOMYCIN INFUSION IN ICU PATIENTS WITH AUGMENTED RENAL CLEARANCE
    Keil, Elizabeth
    Diep, Calvin
    Meng, Lina
    Ran, Ran
    Lorenzo, Javier
    CRITICAL CARE MEDICINE, 2023, 51 (01) : 375 - 375
  • [32] Continuous infusion vs intermittent vancomycin in neurosurgical intensive care unit patients
    Hong, Lisa T.
    Goolsby, Tiffany A.
    Sherman, Deborah S.
    Mueller, Scott W.
    Reynolds, Paul
    Cava, Luis
    Neumann, Robert
    Kiser, Tyree H.
    JOURNAL OF CRITICAL CARE, 2015, 30 (05) : 1153.e1 - 1153.e6
  • [33] Vancomycin penetration of uninfected pleural fluid exudate after continuous or intermittent infusion
    Byl, B
    Jacobs, F
    Wallemacq, P
    Rossi, C
    de Francquen, P
    Cappello, M
    Leal, T
    Thys, JP
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (06) : 2015 - 2017
  • [34] Nephrotoxicity of continuous versus intermittent infusion of vancomycin in outpatient parenteral antimicrobial therapy
    Ingram, Paul R.
    Lye, David C.
    Fisher, Dale A.
    Goh, Wei-Ping
    Tam, Vincent H.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2009, 34 (06) : 570 - 574
  • [35] Emergence of antimicrobial resistance to piperacillin/tazobactam or meropenem in the ICU: Intermittent versus continuous infusion. A retrospective cohort study
    Dhaese, Sofie A. M.
    De Kezel, Magalie
    Callant, Maxime
    Boelens, Jerina
    De Bus, Liesbet
    Depuydt, Pieter
    De Waele, Jan J.
    JOURNAL OF CRITICAL CARE, 2018, 47 : 164 - 168
  • [36] Safety and Efficacy of Intermittent Bolus and Continuous Infusion Neostigmine for Acute Colonic Pseudo-Obstruction
    Smedley, Lucas W.
    Foster, Dana B.
    Barthol, Colleen A.
    Hall, Reed
    Gutierrez, G. Christina
    JOURNAL OF INTENSIVE CARE MEDICINE, 2020, 35 (10) : 1039 - 1043
  • [37] Cost-effectiveness and clinical outcomes of intermittent/continuous proton pump inhibitors infusion in high bleeding risk of ulcers A retrospective observational cohort study
    Hsieh, Hui-Hsia
    Wu, Tien-Yuan
    Chen, Chi-Hua
    Hour, Mann-Jen
    MEDICINE, 2021, 100 (49)
  • [38] Administration of Vancomycin at High Doses in Patients with Post Neurosurgical Meningitis: A Comprehensive Comparison between Continuous Infusion and Intermittent Infusion
    Taheri, Morteza
    Dadashzadeh, Simin
    Shokouhi, Shervin
    Ebrahimzadeh, Kaveh
    Sadeghi, Masoumeh
    Sahraei, Zahra
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2018, 17 : 195 - 205
  • [39] Safety, efficacy and lessons from continuous infusion with rFVIIa
    Schulman, S
    HAEMOPHILIA, 1998, 4 (04) : 564 - 567
  • [40] Efficacy and Safety of Extended Continuous-Infusion Neostigmine
    Foris, L.
    Samad, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
12345